BioCentury
ARTICLE | Company News

BioChem, UroCor sales and marketing update

February 26, 2001 8:00 AM UTC

The companies ended their agreement under which UCOR has been distributing BCHE's Pacis live attenuated Bacillus Calmette-Guerin (BCG) to treat bladder cancer in the U.S. Pursuant to the termination a...